• Linkedin
  • Twitter
  • Youtube
  • Facebook
  • Instagram
HCS Pharma
  • Company
    • About us
    • Team
    • Scientific Advisory Board
    • Advisory Board
    • Investors Relations
    • R&D programs and partnerships
      • BioPharMEMS
      • MIMLIVEROnChip
      • Nanostem
      • NEUROCELL3D
      • ONCO3D
      • RHU CHOPIN
      • ScaLABle-MEAT
      • VisuAI
    • Pressroom
      • Press releases
      • Photos for the press
      • HCS Pharma in press
    • Customer testimonials
    • Labels, prizes and distinctions
    • Partners and Memberships
    • Careers
    • Privacy Policy
  • BIOMIMESYS®
    • What is BIOMIMESYS® hydroscaffold?
    • BIOMIMESYS® Brain
    • BIOMIMESYS® Liver
    • BIOMIMESYS® Adipose tissue
    • BIOMIMESYS® Oncology
    • BIOMIMESYS® Custom
    • How to buy BIOMIMESYS®?
  • Support
    • BIOMIMESYS® Custom
    • Dermocosmetology
      • Anti-Aging
      • Anti-Oxidant
      • Anti-Redness
      • Wound Healing
      • Skin Pigmentation
      • Anti-Pollution
      • Skin Microbiota
      • Cosmetics custom developments
    • Pharmacology
      • Parkinson
      • Alzheimer
      • Migration
      • Cell cycle arrest
  • Ressources
    • Publications – Scientific articles
    • Application Notes
    • Conferences & Webinars
    • News
    • Posters
    • Brochures
    • BIOMIMESYS® tutorials
    • Customer testimonials
    • Certificates of Analysis
    • TDS&MSDS
    • Protocols
    • Frequently Asked Questions
  • Contacts
    • How to contact us?
    • How to buy BIOMIMESYS®?
    • Subscribe to our Newsletter

fluorescence microscopy

News

We will attend HCS User Meeting by Molecular Devices in Leiden next week

We will give a presentation next week (on Tuesday, 10th of March 2020) at the High-Content Cellular Imaging User meeting organized by our partner Molecular Devices, which will take place in Leiden (Netherlands). It is a great pleasure for us to attend the meeting, and to talk about the applications, Read more…

By Elodie Vandenhaute, 3 yearsMarch 3, 2020 ago
Clic to get more information

BIOMIMESYS®

Contacts
Contact us with this form!
Or
+33 769 999 137

Newsletter

Recent Posts
  • Development of devices to study brain and liver metastasis of triple negative breast cancer cells
  • Advantages of 3D Cell Culture in Immuno-Oncology
  • First week of business trip in Asia for Nathalie Maubon (HCS Pharma)
  • Feedback from Molecular Devices’ User Meeting in Copenhagen
  • Meet Nathalie in Boston during BIO International Convention!
We talk about …
3D 3D cell culture 3D culture BIOMIMESYS BIOMIMESYS Brain blood brain barrier brain cancer cell Cell Culture congress cosmetology dermocosmetology drug ECM ELRIG event extracellular matrix genotoxicity HCS hcs pharma High content screening hyaluronic acid imaging innovation in vitro in vitro models liver meeting Microbiota microenvironment microscopy Molecular Devices NEUROCELL3D neurotoxicity ONCO3D oncology organoids Parkinson phenotypic screening picture screening skin toxicology webinar
  • Company
  • BIOMIMESYS®
  • Support
  • Ressources
  • Contacts
HCS Pharma (c) 2021 | Hestia | Powered by WordPress
 

Loading Comments...